Amlodipine inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension

Research Communications in Molecular Pathology and Pharmacology

Volumn 91, Issue 1, 1996, Pages 17-32

  Takahashi, Takashi ^a   Kanda, Tsugiyasu ^a   Imai, Susumu ^a   Suzuki, Tadashi ^b   Kobayashi, Isao ^a   Nagai, Ryozo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Coll of Medical Care and Technology ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; MONOCROTALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG HALF LIFE; HEART MUSCLE CELL; HEART RIGHT VENTRICLE HYPERTROPHY; HEART WEIGHT; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE;

AMLODIPINE; ANIMALS; CALCIUM CHANNEL BLOCKERS; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MALE; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; RATS; RATS, WISTAR;

EID: 0030062130     PISSN: 00345164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Burges, R. and Moisey, D. (1994). Unique pharmacologic properties of amlodipine. Am. J.Cardiol.2A-9A.
2. Burges, R.A., Gardiner, D.G., Gwilt, M., Higgins, A.J., Blackburn, K.J., Campbell, S.F., Cross, P.E. and Stubbs, J.K. (1987). Calcium channel blocking properties of amlodipine in vascular smooth muscle and cardiac muscle in vitro: evidence for voltage modulation of vascular dihydropyridine receptors. J. Cardiovasc. Pharmacol. 9, 110-119.
3. Cassis, L.A., Rippetoe, P.E., Soltis, E.E., Painter, D.J., Fitz, R. and Gillespie, M.N. (1992). Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of Losartan (Dup 753), a nonpeptide angiotensin type 1 receptor antagonist. J. Pharmacol. Exp. Ther. 262, 1168-1172.
4. Dresdale, D.T., Schultz, M. and Michtom, R.J. (1951). Primary pulmonary hypertension. I. Clinical and hemodynamic study. Am. J. Med. 11, 686-705.
5. Farhat, M.Y., Chen, M.F., Bhatti, T., Iqbal, A., Cathapermal, S. and Ramwell, P.W. (1993). Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats. Br. J. Pharmacol. 110, 719-723.
6. Grossman, W. and Braunwald, E. (1992). Pulmonary hypertension. In: Heart Disease. Edited by E. Braunwald. W.B. Saunders. pp 790-816.
7. Kambara, H., Fujimoto, K., Wakabayashi, A. and Kawai, C. (1981). Primary pulmonary hypertension: beneficial therapy with diltiazem. Am. Heart J. 101, 230-231.
8. Matlib, M.A., French, J.F., Grupp, I.L., Gorp, C.V., Grupp, G. and Schwartz, A. (1988). Vasodilatory action of amlodipine on rat aorta, pig coronary artery, human coronary artery, and on isolated Langendorff rat heart preparations. J. Cardiovasc. Pharmacol. 12(Suppl. 7), S50-S54.
9. Meyrick, B. and Reid, L. (1979). Development of pulmonary arterial changes in rats fed Crotalaria spectabilis. Am. J. Pathol. 94, 37-50. Meyrick, B., Gamble, W. and Reid, L. (1980). Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am. J. Physiol. 239, H692-H702
10. Meyrick, B. and Reid, L. (1979). Development of pulmonary arterial changes in rats fed Crotalaria spectabilis. Am. J. Pathol. 94, 37-50. Meyrick, B., Gamble, W. and Reid, L. (1980). Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am. J. Physiol. 239, H692-H702
11. Meyrick, B. and Reid, L. (1979). Development of pulmonary arterial changes in rats fed Crotalaria spectabilis. Am. J. Pathol. 94, 37-50.
12. Nayler, W.G. (1988). The effect of amlodipine on hypertension-induced cardiac hypertrophy and reperfusion-induced calcium overload. J. Cardiovasc. Pharmacol. 12 (Suppl. 7), S41-S44.
13. Pearl, R.G. and Finn, J.C. (1990). Hemodynamic effects of diltiazem during vasoconstrictor pulmonary hypertension in sheep. Anesth. Analg. 71, 493-497.
14. Reeves, W.C., Wood, M.A., Whitesell, L. and Schildt, N. (1985). Effect of diltiazem and ibuprofen on right ventricular hypertrophy in an experimental model of hypoxic pulmonary hypertension. Am. J. Cardiol. 56, 470-472.
15. Rich, S. and Brundage, B.H. (1987). High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 76, 135-141.
16. Rich, S., Kaufmann, E. and Levy, P.S. (1992). The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N. Engl. J. Med. 327, 76-81.
17. Singh, B.N., Baky, S. and Nademanee, K. (1985). Second-generation calcium antagonists: search for greater selectivity and versatility. Am. J. Cardiol. 55, 214B-221B.
18. Stanbrook, H.S., Morris, K.G. and McMurtry, I.F. (1984). Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists. Am. Rev. Respir. Dis. 130, 81-85. Taira, N. (1987). Differences in cardiovascular profile among calcium antagonists. Am. J. Cardiol. 59, 24B-29B.
19. Stanbrook, H.S., Morris, K.G. and McMurtry, I.F. (1984). Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonists. Am. Rev. Respir. Dis. 130, 81-85. Taira, N. (1987). Differences in cardiovascular profile among calcium antagonists. Am. J. Cardiol. 59, 24B-29B.
20. Takahashi, T., Kanda, T., Imai, S., Suzuki, T. and Murata, K. (1994). The beneficial effect of semotiadil on the development of right ventricular hypertrophy and medial proliferation in pulmonary arteries induced by monocrotaline in rats: comparison with diltiazem. Eur. Heart J. 15(Abs. Suppl.), 523(Abs. 2870).
21. Wilson, D.W., Segall, H.J., Pan, L.C., Lame, M.W., Estep, J.E. and Morin, D. (1992). Mechanisms and pathology of monocrotaline pulmonary toxicity. Crit. Rev. Toxicol. 22, 307-325.
22. Woodmansey, P.A., Zhang, F., Channer, K.S. and Morice, A.H. (1995). Effect of the calcium antagonist amlodipine on the two phases of hypoxic pulmonary vasoconstriction in rat large and small isolated pulmonary arteries. J. Cardiovasc. Pharmacol. 25, 324-329.
23. Yang, Z., Noll, G. and Lüscher, T.F. (1993). Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet-derived growth factor. Circulation 88, 832-836.
24. Young, T.E., Lundquist, B.S., Chesler, E. and Weir, E.K. (1983). Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension. Am. J. Cardiol. 51, 195-200.